Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
MUMBAI, India, Feb. 8, 2023 /CNW/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M) ended 31th December…